Scott Kellen - 01 Jun 2023 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role: CFO and Secretary
Signature: /s/ Amy E. Culbert, attorney-in-fact
Issuer symbol: DMAC
Transactions as of: 01 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 02 Jun 2023, 16:46:23 UTC
Previous filing: 02 Jun 2022
Next filing: 26 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DMAC	Voting Common Shares, no par value per share						22,290	01 Jun 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DMAC	Stock Option (right to buy)	Award	$0	+67,000		$0.000000	67,000	01 Jun 2023	Common Shares	67,000	$2.73	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Vests with respect to 25% of the underlying common shares on June 1, 2024 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2024.